These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5656779)

  • 1. Bulk compounding technology.
    Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bacterial content control and study of aseptic procedure in preparation of infusion solutions].
    Bábik I; Sagáth J
    Pharm Prax; 1968; 2():34-7. PubMed ID: 5731460
    [No Abstract]   [Full Text] [Related]  

  • 3. Parenteral formulation. VI. Hydrolytic degradation of esters in parenteral solutions.
    Anschel J; Mollica JA; Lin KS
    Bull Parenter Drug Assoc; 1972; 26(6):271-89. PubMed ID: 4629105
    [No Abstract]   [Full Text] [Related]  

  • 4. Particulate matter in parenteral solutions.
    Med Lett Drugs Ther; 1968 May; 10(11):42-4. PubMed ID: 5656614
    [No Abstract]   [Full Text] [Related]  

  • 5. [Summary of the discussion on the subject of: "technical problems in the production and use of infusion solutions"].
    Klin Anasthesiol Intensivther; 1977; (14):95-105. PubMed ID: 926695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA
    Pharm Weekbl; 1969 Sep; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract]   [Full Text] [Related]  

  • 7. The bulk compounding of technology of liquids and semi-solids.
    Schumacher GE
    Am J Hosp Pharm; 1969 Feb; 26(2):70-99. PubMed ID: 5766229
    [No Abstract]   [Full Text] [Related]  

  • 8. Preservative combinations: a microbiological assessment.
    Wakely JH; Hall NC; Krezanoski JZ
    Bull Parenter Drug Assoc; 1967; 21(4):124-35. PubMed ID: 6045458
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basis of infusion solutions. III. Systematization and directions for the use of infusion solutions].
    Schmitz JE; Ahnefeld FW
    Beitr Infusionther Klin Ernahr; 1980; 5():29-47. PubMed ID: 7192092
    [No Abstract]   [Full Text] [Related]  

  • 10. Determining osmolarities: a practical approach for multicomponent intravenous and parenteral nutrient solutions.
    Gatlin L; Kulkarni P; Hussain A; DeLuca PP
    Am J Hosp Pharm; 1979 Oct; 36(10):1357-61. PubMed ID: 116545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Basic rules for the production of infusion solutions and in the ensuring of their quality].
    Ganshirt KH; Pauli W; Rössler R
    Klin Anasthesiol Intensivther; 1977; (14):1-17. PubMed ID: 926675
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2.
    Allen LV; Stiles ML
    Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755
    [No Abstract]   [Full Text] [Related]  

  • 13. A new batch method of preparing intravenous piggyback solutions in polyvinylchloride containers.
    Levy R; Kleinberg M; Lee P
    Hosp Pharm; 1980 Oct; 15(10):504-6. PubMed ID: 10309298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of compounding changes in parenteral injections by thin-layer chromatography. 1].
    Tanaka K; Sakamoto Y; Nakai T
    Iryo; 1968 Oct; 22(10):1109-14. PubMed ID: 4885315
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous versus intermittent intravenous antibiotics.
    Med Lett Drugs Ther; 1968 Jul; 10(15):57-8. PubMed ID: 5667663
    [No Abstract]   [Full Text] [Related]  

  • 16. Bulk compounding in Canadian hospitals--a survey.
    Taddio A; Wilson W
    Can J Hosp Pharm; 1990 Oct; 43(5):213-8, xxxii. PubMed ID: 10107923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous administration of drugs.
    Paris P; Hans P; Lamy M
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):109-15. PubMed ID: 6613510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulk compounding technology. The palatability of bulk compounded products. 3.
    Schumacher GE
    Am J Hosp Pharm; 1968 Mar; 25(3):154-6. PubMed ID: 5658861
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for phenytoin infusions.
    Tuttle CB
    Can J Hosp Pharm; 1984; 37(4):137-9. PubMed ID: 10269318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral incompatibilities--past, present and future.
    Parker EA; Boomer RJ; Bell SC
    Bull Parenter Drug Assoc; 1967; 21(6):197-207. PubMed ID: 6078886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.